| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 41 |
| 1 | VALPROIC ACID | 39 |
| 2 | CARBAMAZEPINE | 38 |
| 3 | ARIPIPRAZOLE | 36 |
| 4 | METHYLPHENIDATE HYDROCHLORIDE | 35 |
| 5 | ARIPIPRAZOLE ORAL | 34 |
| 6 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 34 |
| 7 | CLONIDINE | 34 |
| 8 | CHLORPROMAZINE | 33 |
| 9 | LITHIUM | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPERIDONE | 31 | 0.0210 |
| 1 | ZIPRASIDONE | 32 | 0.0089 |
| 2 | CHLORPROMAZINE | 33 | 0.0053 |
| 3 | LITHIUM | 32 | 0.0013 |
| 4 | VALPROIC ACID | 39 | 0.0012 |
| 5 | AMPHETAMINE SULFATE TABLETS | 2 | 0.0012 |
| 6 | AMISULPRIDE | 6 | 0.0010 |
| 7 | TROFINETIDE | 7 | 0.0010 |
| 8 | METHYLPHENIDATE HCL | 1 | 0.0008 |
| 9 | AZELASTINE HCL | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 62 |
| 1 | Anti-epileptic Agent [EPC] | 57 |
| 2 | Mood Stabilizer [EPC] | 55 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 34 |
| 4 | Central Nervous System Stimulant [EPC] | 32 |
| 5 | Corticosteroid [EPC] | 26 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 7 | Benzodiazepine [EPC] | 22 |
| 8 | Proton Pump Inhibitor [EPC] | 17 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 6 | 0.0008 |
| 1 | Central alpha-2 Adrenergic Agonist [EPC] | 34 | 0.0006 |
| 2 | Central Nervous System Stimulant [EPC] | 32 | 0.0004 |
| 3 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | Anti-epileptic Agent [EPC] | 57 | 0.0003 |
| 6 | Mood Stabilizer [EPC] | 55 | 0.0003 |
| 7 | Phenothiazine [EPC] | 6 | 0.0002 |
| 8 | Typical Antipsychotic [EPC] | 4 | 0.0002 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |